THURSDAY, JUNE 26
Session 3B: 1:30 -2:30 PM
Fellows’ room: learn from the Editors of Journals
Moderators: Stuart Spencer (Brenzett, GBR), Harriette Van Spall (Hamilton, CAN)
Master tips to convince the reviewers – Arianna Colosio (Lancet Respiratory Medicine, GBR)
Figures are key – Christian Jung (Düsseldorf, DEU)
What matters in the statistical review – Michael Harhay (Pennsylavia, USA
)My advice to answer to reviewers – Biykem Bozkurt (Houston, USA)
Panel discussion with all the above
FRIDAY, JUNE 27
Session 6B: 8:30- 10:00 AM
Preventing renal damage in the critically ill: a transdisciplinary effort!
Moderators: Pascal LePrince (Paris, FRA), Alexandre Mebezaa (Paris, FRA)
How to prevent AKI in ICU? - Marlies Ostermann (London, GBR)
Main drivers of AKI – Rafael Kramann (Aachen, DEU)
Lessons from Dan-Ger shock trial? – Erlic Zweck (Düsseldorf, DEU)
Trail design to assess therapies that prevent worsening AKI – Peter Pickkers (Nijmegen, NLD)
Post-discharge management after AKI – François Depret (Paris, FRA)
Industry Perspective - Abiomed, AM-Pharma Regulatory point of view - Maciej Kostrubiec (EMA, POL)
Panel discussion with all the above
Additional Panelist : Louis Mourisse, Aliza Thompson (FDA, USA)
Medical Rapporteurs - François Depret (Paris, FRA), Elric Zweck (Düsseldorf, DEU)
Session 7B : 10:30 AM - 12:00 PM
How to design an escalating dose in critical care?
Moderators: Alexandre Mebazaa (Paris, FRA), Harriette Van Spall (Hamilton, CAN)
Phase 2 is not a "small" phase 3 trial – Harriette Van Spall (Hamilton, CAN)
Bayesian adaptive two-stage design – Anastasia Ivanova (Chapel Hill, USA)
Statistical thoughts on phase 2 trials in critical care – Janet Wittes (Washington, USA)
Learning from recent phase 2 trials in ICU – Michael Harhay (Pennsylavia, USA)
Industry perspective - Bayer, Karine Bourgeois (4Teen4, DEU)
Panel discussion with all the above
Session 8B : 1:00 - 3:00 PM
Assessing congestion in heart failure: tools are already available
Moderators: Nicolas Girerd (Nancy, FRA), Maria Rosa Costanzo (Naperville, USA), Naoki Sato (Tokyo, JPN)
Is there a gold standard to assess congestion? – Marat Fudim (Durham, USA)
Inferior vena cava diameters – Mandeep Mehra (Boston, USA)
Liver stiffness – Jan Biegus (Wrocław, POL)
Assessing congestion at home: COSI-HOME study – Alexandre Mebazaa (Paris, FRA)
Monitoring pulmonary artery pressure – Maria Rosa Costanzo (Naperville, USA)
Industry Perspective - Echosens, Juuso Blomster (CardioSignal)
Patient are ready to act - Nick Hartshorne - Nick Hartshorne-Evans (Preston, GRB)
Panel discussion with all the above Additional Panelist : Sean Collins (Brentwood, USA), Mattia Arrigo (Zürich, CHE), Mitchell Psotka (FDA, USA), Jordan Pomeroy (FDA, USA)
Medical Rapporteurs - Jolie Bruno (Berne, CHE), Nicolas Girerd (Paris, FRA)
Session 9B: 3:30 - 5:00 PM
Round table: Time for a Global CS collaboratory?
Moderators: Sabri Soussi (Toronto, CAN), Susanna Price (London, GBR), Shashank Sinha (Falls Church, USA), Naoki Sato (Tokyo, JPN)
Biobanking is key in CS collaborative research – Phyllis Billia (Toronto, CAN)
Clinical trials in CS research – Rebecca Mathew (Ottawa, CAN)
Network of networks in CS research: the ShockCO-OP consortium initiative – Sabri Soussi (Toronto, CAN)
Data sharing – Naoki Sato (Tokyo, JPN)
Omics-based biomarkers in CS research – Alastair Proudfoot (London, GBR)
Urgent need for cardiac arrest trials – Shir Lynn Lim (Singapore, SGP)
